ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11 | -100.0% | 18,256 | -62.0% | 0.00% | – |
Q4 2021 | $52,000 | -95.5% | 48,063 | -92.5% | 0.00% | -100.0% |
Q3 2021 | $1,163,000 | +82.3% | 639,207 | +164.2% | 0.01% | +16.7% |
Q2 2021 | $638,000 | +303.8% | 241,922 | +554.2% | 0.01% | -14.3% |
Q3 2019 | $158,000 | -16.8% | 36,981 | +132.8% | 0.01% | -92.1% |
Q2 2015 | $190,000 | – | 15,885 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |